Indiana Congressmen Rudy Yakym and André Carson have introduced a bipartisan bill aimed at cracking down on untested and potentially dangerous mass-produced compounded drugs.
The proposal, called the SAFE Drugs Act of 2025 (H.R. 6509), would require regular inspections of compounding facilities, strengthen reporting requirements, and give the FDA more resources to monitor drug safety.
Yakym said the bill is meant to restore confidence in prescription medications by ensuring they are safe, effective, and made to high standards. Carson added that some companies are selling risky, substandard products, and the legislation would tighten oversight and improve quality controls.
Several major patient-advocacy groups have endorsed the measure, citing growing concerns about widely marketed, non-FDA-approved compounded versions of popular GLP-1 and similar medications used for diabetes and obesity.
The American Diabetes Association, Obesity Action Coalition, and Partnership for Safe Medicines each issued statements supporting stronger inspections, stricter reporting, and safeguards against illegal mass compounding. They say the bill would help ensure patients receive medications that meet proper safety and quality standards.
1 comment
This bill is really a scheme to protect big pharma from competition. So the rest of us, the average Joe and Jill that do not have a government job with YUGE health care benefits, will still pay through the nose for name brand drugs that cost a tenth in other countries they cost here.
Perhaps of Rudy let constituents post more than 2000 characters on his government website I pay for he would know where The People of the 3rd District stand.
I remind others that our two US Senators and Rudy’s predecessor NEVER limit what can be e-mailed to them.